Implications of HIV drug resistance on first- and second-line therapies in resource-limited settings: report from a workshop organized by the Collaborative HIV and Anti-HIV Drug Resistance Network

Pillay, D.; Albert, J.; Bertagnolio, S.; Boucher, C.; Brun-Vezinet, F.; Clotet, B.; Giaquinto, C.; Perno, C.F.; Pillay, D; Albert, J; Bertagnolio, S; Boucher, C; Brun-Vezinet, F; Clotet, B; Giaquinto, C; Perno, C.F

doi:10.3851/imp2650

Home

>

Node

>

Subnode

Implications of HIV drug resistance on first- and second-line therapies in resource-limited settings: report from a workshop organized by the Collaborative HIV and Anti-HIV Drug Resistance Network

Pillay, D.; Albert, J.; Bertagnolio, S.; Boucher, C.; Brun-Vezinet, F.; Clotet, B.; Giaquinto, C.; Perno, C.F.

Antiviral Therapy 18(6): 831-836

2013

ISSN/ISBN: 1359-6535

PMID: 23740717

DOI: 10.3851/imp2650

Document Number: 627167

Here, we summarize the discussions and conclusions from an expert workshop held in October 2012 to consider the implications of HIV drug resistance in the context of scale-up of access to antiretroviral therapy and prophylaxis in resource-limited settings. Topics considered during the workshop included the implications of drug resistance for the selection of first-line regimens and sequencing of treatments, optimal surveillance strategies and prevention of mother-to-child transmission.